Companies: 10,795·Total market cap: $144.5T
Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTKNASDAQHealthcare● Active
$67.90
$-3.58(-5.01%)
Market Cap$8.4B
P/E Ratio
52W High$80.2
52W Low$31.99
Overview

Cytokinetics, Incorporated(CYTK)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CYTK · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$882.22M$1076.01M$614.82M$782.58M$471.64M
Net Receivables$0.00M$16.65M$1.28M$0.15M$51.82M
Inventory$0.00M$0.00M$0.00M$0.00M$0.00M
Total Current Assets$916.98M$1107.94M$628.05M$795.19M$535.67M
PP&E Net$155.17M$140.97M$147.74M$163.19M$146.41M
Goodwill$0.00M$0.00M$0.00M$0.00M$0.00M
Intangible Assets$0.00M$0.00M$0.00M$0.00M$0.00M
Total Assets$1424.54M$1401.67M$824.32M$1014.77M$841.32M
Liabilities
Short-Term Debt$41.18M$11.52M$10.08M$0.96M$0.00M
Accounts Payable$105.61M$20.37M$21.51M$25.61M$21.09M
Total Current Liabilities$202.45M$179.67M$102.68M$84.62M$71.86M
Long-Term Debt$1115.98M$645.60M$607.37M$609.62M$142.84M
Total Liabilities$2084.16M$1537.05M$1210.64M$1122.67M$597.46M
Stockholders Equity
Retained Earnings($3486.72M)($2701.76M)($2112.24M)($1585.99M)($1207.62M)
Total Stockholders Equity($659.63M)($135.37M)($386.32M)($107.90M)$243.86M
Total Liab & Equity(computed)$1424.54M$1401.67M$824.32M$1014.77M$841.32M
Debt Summary
Total Debt$1284.24M$788.68M$755.77M$750.30M$269.93M
Net Debt$402.02M$693.82M$642.75M$684.72M$157.26M

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Cytokinetics, Incorporated

关于Cytokinetics, Incorporated(CYTK)资产负债表

Cytokinetics, Incorporated总资产$1.42B,现金及短期投资$0.88B,总负债$2.08B,总债务$1.28B,股东权益($0.66B)。

常见问题

CYTK · 4 问

Cytokinetics, Incorporated总债务$1.28B,净债务$0.40B。

CYTK total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10